A-Kinase Anchoring Proteins (AKAPs) are pivotal in targeting the cAMP-dependent protein kinase (PKA) to specific cellular locations, which is critical for the specificity of PKA signaling. AKAP 10 is a member of this family that anchors PKA within certain intracellular compartments, particularly in the heart and in pancreatic beta cells, where it regulates processes such as cardiac myocyte contraction and insulin secretion. Chemicals that increase intracellular cyclic adenosine monophosphate (cAMP) can enhance AKAP 10 activity by facilitating the anchoring of PKA and thus promoting phosphorylation events at those sites. For instance, cAMP itself binds directly to the regulatory subunits of PKA, promoting its activation and interaction with AKAP 10.
Compounds that either increase the production of cAMP (like Forskolin, which activates adenylyl cyclase) or inhibit the degradation of cAMP (such as specific phosphodiesterase inhibitors) can indirectly amplify AKAP 10-mediated signaling. By ensuring a higher concentration of cAMP within the cell, these compounds maintain PKA in its active form and promote its association with AKAP 10. This amplification of the cAMP-PKA pathway leads to enhanced phosphorylation of target proteins at locations dictated by AKAP 10, thereby fine-tuning cellular responses that are critical for physiological functions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP directly binds to AKAPs, enhancing their ability to anchor PKA and regulate its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP levels, thereby enhancing AKAP 10's ability to localize PKA. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specifically inhibits phosphodiesterases, increasing cAMP and PKA anchoring via AKAP 10. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Stimulates adenylyl cyclase, boosting cAMP and AKAP 10's PKA anchoring capacity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Inhibits PDE4, elevating cAMP levels thereby potentiating AKAP 10-dependent PKA anchoring. | ||||||
PKI (14-22) amide (myristoylated) | 201422-03-9 | sc-471154 | 0.5 mg | $135.00 | 2 | |
Inhibits PKA, which may indirectly upregulate AKAP 10's PKA anchoring in feedback. | ||||||
Sp-cAMPS | 93602-66-5 | sc-201571 | 1 mg | $97.00 | 3 | |
cAMP analog that binds to AKAPs, enhancing their PKA anchoring ability, including AKAP 10. | ||||||
8-pCPT-2′-O-Me-cAMP | 634207-53-7 | sc-257020 | 1 mg | $306.00 | 5 | |
cAMP analog that activates PKA and could enhance AKAP 10's effectiveness in PKA anchoring. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that diffuses into cells and enhances PKA anchoring by AKAP 10. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Inhibits PDE3, increasing cAMP levels and potentially enhancing AKAP 10-mediated PKA anchoring. | ||||||